| Literature DB >> 35317384 |
Ozgun Karakus1, Burak Gurer2, Selcuk Kilic1, Ahmet Sinan Sari2.
Abstract
Objectives: The aim of this study was to investigate the effect of subacromial decompression on the results of full thickness rotator cuff repair applied arthroscopically. Examination was also made of the effect of acromion type on the subacromial decompression procedure in patients applied with arthroscopic rotator cuff repair.Entities:
Keywords: Acromion; bursitis; rotator cuff impingement; rotator cuff tears; shoulder pain
Year: 2021 PMID: 35317384 PMCID: PMC8907701 DOI: 10.14744/SEMB.2021.12354
Source DB: PubMed Journal: Sisli Etfal Hastan Tip Bul ISSN: 1302-7123
Demographic characteristics according to the groups
|
|
|
|
|
| |
|---|---|---|---|---|---|
| Age (years) | |||||
| Min–Max (Median) | 46–86 (65.5) | 48–81 (67) | 46–81 (65) | 46–86 (61) | 0.786a |
| Mean±SD | 65.63±9.22 | 66.36±8.81 | 65.40±9.60 | 65.14±9.36 | |
| Gender; n (%) | |||||
| Female | 102 (68.0) | 30 (60.0) | 36 (72.0) | 36 (72.0) | 0.332b |
| Male | 48 (32.0) | 20 (40.0) | 14 (28.0) | 14 (28.0) | |
| Side; n (%) | |||||
| Right | 95 (63.3) | 35 (70.0) | 25 (50.0) | 35 (70.0) | 0.057b |
| Left | 55 (36.7) | 15 (30.0) | 25 (50.0) | 15 (30.0) |
aOne-way ANOVA test; bPearson Chi-square test.
Evaluation of CM, ASES, VAS scores, and acromion types according to the groups
|
|
|
|
|
| |
|---|---|---|---|---|---|
| CM score | |||||
| Pre-operative | |||||
| Min–Max (Median) | 35–48 (39) | 35–48 (39) | 36–48 (39) | 36–48 (39) | 0.875a |
| Mean±SD | 39.55±2.32 | 39.68±2.60 | 39.54±2.30 | 39.44±2.07 | |
| Post-operative | |||||
| Min-Max (Median) | 72–89 (80) | 76–89 (80) | 72–87 (80) | 72–89 (82) | 0.470a |
| Mean±SD | 81.12±2.73 | 81.00±2.49 | 80.86±2.61 | 81.50±3.06 | |
| Pd | 0.001** | 0.001** | 0.001** | ||
| Pre-operative-post-operative difference | |||||
| Min-Max (Median) | 32–50 (42) | 32–49(41.5) | 32–49 (42) | 32–50 (42) | 0.443a |
| Mean±SD | 41.57±3.33 | 41.32±3.33 | 41.32±3.15 | 42.06±3.52 | |
| ASES score | |||||
| Pre-operative | |||||
| Min-Max (Median) | 20–32 (24) | 20–32 (23) | 20–32 (23) | 21–32 (25) | 0.975a |
| Mean±SD | 24.07±2.83 | 24.10±2.83 | 24.00±2.98 | 24.12±2.72 | |
| Post-operative | |||||
| Min–Max (Median) | 68–93 (80) | 70–93 (80) | 68–93 (80) | 70–93 (80) | 0.881a |
| Mean±SD | 79.89±4.14 | 79.90±3.68 | 79.68±3.94 | 80.10±4.80 | |
| Pd | 0.001** | 0.001** | 0.001** | ||
| Pre-operative-post-operative difference | |||||
| Min–Max (Median) | 41–72 (56) | 48–71 (56) | 46–72 (56) | 41–72 (56) | 0.955a |
| Mean±SD | 55.82±4.94 | 55.80±4.25 | 55.68±4.64 | 55.98±5.88 | |
| VAS score | |||||
| Pre-operative | |||||
| Min–Max (Median) | 4–10 (8) | 4–9 (8) | 4–9 (8) | 5–10 (8) | 0.332c |
| Mean±SD | 7.51±1.19 | 7.56±1.13 | 7.32±1.24 | 7.66±1.19 | |
| Post-operative | |||||
| Min–Max (Median) | 1–7 (2) | 1–4 (1) | 1–4 (1) | 1–7 (2) | 0.032*c |
| Mean±SD | 1.79±1.11 | 1.56±0.73 | 1.60±0.78 | 2.22±1.52 | |
| Pe | 0.001** | 0.001** | 0.001** | ||
| Pre-operative-post-operative difference | |||||
| Min–Max (Median) | −9–−2 (−6) | −8–−2 (−6) | −8–−2 (−6) | −9–−2 (−6) | 0.175c |
| mean±SD | −5.72±1.49 | −6.00±1.34 | −5.72±1.50 | −5.44±1.61 | |
| Acromion type | |||||
| n (%) | |||||
| Pre-operative | |||||
| Type 1 | 59 (39.3) | 20 (40.0) | 22 (44.0) | 17 (34.0) | 0.771b |
| Type 2 | 63 (42.0) | 19 (38.0) | 20 (40.0) | 24 (48.0) | |
| Type 3 | 28 (18.7) | 11 (22.0) | 8 (16.0) | 9 (18.0) | |
| Post-operative | |||||
| Type 1 | 61 (40.7) | 24 (48.0) | 20 (40.0) | 17 (34.0) | 0.101b |
| Type 2 | 71 (47.3) | 25 (50.0) | 22 (44.0) | 24 (48.0) | |
| Type 3 | 18 (12.0) | 1 (2.0) | 8 (16.0) | 9 (18.0) | |
aOne-way ANOVA test; bPearson Chi-square test; *p<0.05; **p<0.01; cKruskal Wallis test; dPaired Samples t-test; eWilcoxon Signed-Ranks test. ASES: American shoulder and elbow surgeons score; CM: Constant Murley score; VAS: Visual analog score.
Evaluation of post-operative VAS scores according to post-operative acromion types
|
|
|
|
| ||
|---|---|---|---|---|---|
|
|
|
| |||
| Group A | |||||
| Type 1 | 24 | 1.88 | 0.80 | 1–4 ( | |
| Type 2 | 25 | 1.28 | 0.54 | 1–3 ( | 0.003** |
| Type 3 | 1 | 1.00 | . | 1–1 ( | |
| Group B | |||||
| Type 1 | 20 | 1.95 | 0.89 | 1–4 ( | |
| Type 2 | 22 | 1.23 | 0.43 | 1–2 ( | 0.011* |
| Type 3 | 8 | 1.75 | 0.89 | 1–3 (1.5) | |
| Total | 50 | 1.60 | 0.78 | 1–4 ( | |
| Group C | |||||
| Type 1 | 17 | 1.94 | 0.75 | 1–3 ( | |
| Type 2 | 24 | 1.58 | 0.65 | 1–3 (1.5) | 0.002** |
| Type 3 | 9 | 4.44 | 2.19 | 1–7 ( |
cKruskal–Wallis test; fMann–Whitney U test. VAS: Visual analog score.
Within group evaluations of pre-operative and post-operative acromion types
|
|
|
|
| |||
|---|---|---|---|---|---|---|
|
|
|
|
| |||
|
|
|
|
| |||
| Group A | ||||||
| Type 1 | 14 (28.0) | 6 (12.0) | 4 (8.0) | 24 (48.0) | 0.016* | |
| Type 2 | 6 (12.0) | 13 (26.0) | 6 (12.0) | 25 (50.0) | ||
| Type 3 | 0 (0) | 0 (0) | 1 (2.0) | 1 (20.0) | ||
| Total | 20 (40.0) | 19 (38.0) | 11 (22.0) | 50 (100.0) | ||
| Group B | ||||||
| Type 1 | 20 (40.0) | 0 (0) | 0 (0) | 20 (40.0) | 0.157 | |
| Type 2 | 2 (4.0) | 20 (40.0) | 0 (0) | 22 (44.0) | ||
| Type 3 | 0 (0) | 0 (0) | 8 (16.0) | 8 (16.0) | ||
| Total | 22 (44.0) | 20 (40.0) | 8 (16.0) | 50 (100.0) | ||
| Group C | ||||||
| Type 1 | 17 (34.0) | 0 (0) | 0 (0) | 17 (34.0) | 1.000 | |
| Type 2 | 0 (0) | 24 (48.0) | 0 (0) | 24 (48.0) | ||
| Type 3 | 0 (0) | 0 (0) | 9 (18.0) | 9 (18.0) | ||
| Total | 17 (34.0) | 24 (48.0) | 9 (18.0) | 50 (100.0) | ||
fMarginal Homogeneity test; *p<0.05.